Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

48.17EUR
15 Nov 2019
Change (% chg)

€0.44 (+0.93%)
Prev Close
€47.72
Open
€48.12
Day's High
€48.26
Day's Low
€47.67
Volume
1,531,765
Avg. Vol
1,770,614
52-wk High
€53.94
52-wk Low
€38.28

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Buy/Sell

Sell Hold Buy
2.04 Mean rating from 24 analysts

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88

UPDATE 2-European shares break six-day winning streak, focus moves to Fed

* Healthcare group Fresenius gains on Q3 revenue beat (Updates market action, adds comment, background)

UPDATE 3-Fresenius beats Q3 forecasts with strong sales of home dialysis treatments

* Fresenius highlights infusion drugs unit growth in emerging markets (Adds details from conference call and analyst comments, updates share price)

Photo

Fresenius beats third-quarter forecasts with strong sales of home dialysis treatments

German healthcare group Fresenius beat third-quarter revenue forecasts on Tuesday, citing a solid performance by its infusion drugs unit in emerging markets and strong growth in home treatment at its separately listed dialysis business.

European shares take a pause, focus turns to earnings

Oct 29 European shares retreated from a near two-year high on Tuesday as investors parsed through a mixed bag of earnings, with optimism surrounding the U.S.-China trade progress and Brexit keeping losses in check.

German stocks - Factors to watch on October 29

BERLIN/FRANKFURT, Oct 29 The following are some of the factors that may move German stocks on Tuesday:

Fresenius reports Q3 beat thanks to Kabi growth in emerging markets

Oct 29 German healthcare group Fresenius beat third-quarter revenue forecasts on Tuesday as softer revenue growth in North America was offset by growth of its infusions drugs unit Kabi in emerging markets.

First African-American nominated for Delaware Supreme Court

WILMINGTON, Del., Oct 24 Delaware Governor John Carney nominated on Thursday the first African-American to serve on the state's supreme court and also nominated a current member of the court to take over as chief justice, filling a vacancy due to the retirement of Leo Strine.

Photo

Deutsche Bank's chairman best paid among German blue chips in 2018

FRANKFURT Deutsche Bank's Paul Achleitner was the best paid chairman of a German blue-chip company last year, according to a study published Tuesday.

Deutsche Bank's chairman best paid among German blue chips in 2018

FRANKFURT, Oct 8 Deutsche Bank's Paul Achleitner was the best paid chairman of a German blue-chip company last year, according to a study published Tuesday.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.51%
Rohstoffe +0.57%
Industrie +0.14%
Konjunktur abhängige Waren & Dienstleistungen +0.17%
Konjunktur unabhängige Waren & Dienstleistungen +0.48%
Finanzindustrie +1.82%
Pharma +0.99%
Technologie +0.43%
Telekommunikation +0.28%